MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced ...
RAHWAY, N.J.--(BUSINESS WIRE)-- Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced ...
FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs ...
Dogs across the U.S. could soon get longer-lasting protection against pesky parasites thanks to a new treatment approved by federal regulators Thursday. NOTE: This video is from a previous report. The ...
Merck’s (MRK) animal health unit announced that the U.S. FDA approved a label expansion for its once-yearly parasiticide treatment Bravecto Quantum to treat two additional tick species in dogs.
Bravecto Quantum, a breakthrough, long-acting flea and tick treatment and preventative for dogs, will be available soon. Made by Merck Animal Health, the once-yearly shot can protect dogs for up to 12 ...
Pharma giant Merck has gone to the dogs! Or, at least, its Merck Animal Health business. A new twist on the company’s two-year-old “Bravo, Bravecto!” ad campaign provides a dog’s perspective on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results